Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

Diet Is the Biggest Longevity Lever Most People Underuse

by Team Lumida
February 5, 2026
in Health and Longevity
Reading Time: 3 mins read
A A
0
poached egg with vegetables and tomatoes on blue plate

Photo by Brooke Lark on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key takeaways

  • The NHS “Eatwell” approach emphasizes variety + proportions across 5 food groups, plus hydration, to support healthy weight and overall health.
  • Most people (UK context) are eating too many calories, too much saturated fat/sugar/salt, and too little fruit/veg, fibre, and oily fish—creating preventable chronic-risk exposure.
  • Practical targets are simple: 5+ fruit/veg portions daily, base meals on higher-fibre starches, include protein sources, and prefer unsaturated fats in small amounts.
  • Guidance flags key risk reducers: cut red/processed meat, manage sugary drinks/juice, and keep salt/saturated fat low to support blood pressure, cholesterol, and heart risk.

What Happened?
The NHS published a consumer-friendly guide to eating a healthy, balanced diet, built around the Eatwell Guide. It recommends specific daily habits (like 5 portions of fruit/veg, higher-fibre starchy foods, adequate protein and dairy/alternatives, unsaturated fats in moderation, and sufficient fluids) while advising that foods high in fat, salt, and sugar should be eaten less often and in smaller amounts. It also notes that people with medical conditions or special dietary needs should seek professional advice.

Why It Matters?
This is a standardized “behavioral blueprint” for reducing lifestyle-driven health risks at population scale. The guidance directly targets major, high-cost chronic conditions (cardiovascular disease, stroke risk via blood pressure, obesity, tooth decay, and some cancers) by focusing on the highest-leverage variables: calorie balance, fibre intake, fat quality, and salt/sugar reduction. For investors, it reinforces the ongoing demand tailwinds for healthier food categories (high-fibre staples, protein quality, lower-sugar dairy/alternatives, and better-for-you snacks) and sustained pressure on ultra-processed, high-sugar/high-salt categories as public-health messaging strengthens.

What’s Next?
Expect continued policy and consumer momentum toward measurable nutrition targets (fibre, sugar, salt, saturated fat) and clearer labeling/health claims scrutiny. Watch for increased adoption of structured weight-management programs (like the NHS 12-week plan) as obesity prevalence remains high, and for product reformulation and portfolio shifts by food manufacturers toward “Eatwell-aligned” offerings—especially lower sugar/salt options, higher-fibre carbs, and functional protein products.

Previous Post

New START Expires, Leaving US-Russia Nuclear Limits Without a Binding Framework

Next Post

Anthropic’s Breakout Week Triggers AI “Moat Panic” and Reorders the Competitive Race

Recommended For You

Rare Glioblastoma Survivors Are Rewriting the Playbook—and Pointing to New Therapies

by Team Lumida
3 days ago
Rare Glioblastoma Survivors Are Rewriting the Playbook—and Pointing to New Therapies

Key takeaways Powered by lumidawealth.com Researchers are rethinking glioblastoma as a distributed, neuron-connected network—not just a tumor mass—helping explain why standard therapies often fail. New evidence shows tumor cells...

Read more

VO₂ Max Is the Longevity Multiplier

by Team Lumida
6 days ago
silhouette photography of woman doing yoga

Key takeaways Powered by lumidawealth.com Higher VO₂ max is strongly associated with lower all-cause mortality. Moving from low to moderate fitness can cut mortality risk dramatically. Cardiorespiratory fitness often...

Read more

The Hidden Cost of ‘Sleep Shame’: How Social Pressure Is Undermining Rest—and Performance

by Team Lumida
7 days ago
woman sleeping on bed under blankets

Key takeaways Powered by lumidawealth.com “Sleep shame” is emerging as a social and psychological stressor, affecting both early birds and night owls. Cultural norms that equate productivity with early...

Read more

Green Veggies Are the Longevity Hack You Need to Eat Every Day

by Team Lumida
1 week ago
a close up of a bunch of green plants

Key takeaways Powered by lumidawealth.com Green vegetables like spinach, kale, and broccoli are rich in antioxidants, fiber, and essential vitamins, which can boost health and longevity. A plant-based diet...

Read more

VO₂ Max Is the Longevity Fitness Metric Most People Ignore

by Team Lumida
2 weeks ago
a woman wearing a mask and running in a field

Key Takeaways Powered by lumidawealth.com VO₂ max is one of the strongest measurable predictors of longevity and all-cause mortality. Higher VO₂ max reflects better heart, lung, and mitochondrial function...

Read more

Melatonin Is the Sleep Timing Hack — Not a Knockout Pill

by Team Lumida
2 weeks ago
Melatonin Is the Sleep Timing Hack — Not a Knockout Pill

Key Takeaways Powered by lumidawealth.com Melatonin works best as a circadian “time cue” (sleep schedule/jet lag), not as a general sedative for chronic insomnia. Timing matters more than dose:...

Read more

Sleep Regularity Is the Longevity Hack

by Team Lumida
2 weeks ago
woman sleeping on bed under blankets

Key Takeaways: Powered by lumidawealth.com Sleep regularity often matters more than total sleep duration for long-term health outcomes. Irregular sleep schedules are linked to higher risks of metabolic disease,...

Read more

Morning Sunlight: The Low-Effort Longevity Habit That Resets Your Biology

by Team Lumida
2 weeks ago
sun setting over the mountains

Key Takeaways: Powered by lumidawealth.com 5–15 minutes of morning sunlight exposure helps anchor your circadian clock and improve nighttime sleep. Better circadian alignment is linked to improved metabolism, hormone...

Read more

Protein Timing: The Longevity Hack You Didn’t Know You Needed

by Team Lumida
3 weeks ago
a container of protein powder next to a spoon

Key Takeaways: Powered by lumidawealth.com Protein intake, especially when spread throughout the day, supports muscle maintenance and longevity. Consuming protein-rich meals in the morning and after workouts maximizes muscle...

Read more

Alzheimer’s Diagnosis Is Fracturing—And Patients Are Caught in the Middle

by Team Lumida
3 weeks ago
doctor holding red stethoscope

Key takeaways Powered by lumidawealth.com Competing diagnostic standards are leading to contradictory Alzheimer’s diagnoses for the same patient. One camp defines Alzheimer’s biologically by amyloid presence, while another requires...

Read more
Next Post
Anthropic’s Breakout Week Triggers AI “Moat Panic” and Reorders the Competitive Race

Anthropic’s Breakout Week Triggers AI “Moat Panic” and Reorders the Competitive Race

Musk Combines SpaceX and xAI in a $1.25T Megamerger Ahead of a Summer IPO

Musk Combines SpaceX and xAI in a $1.25T Megamerger Ahead of a Summer IPO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Climate Alarm Fades as Affordability Takes Center Stage

Climate Alarm Fades as Affordability Takes Center Stage

December 13, 2025
a google sign in front of some bushes and trees

Google’s AI Spending Spree Fails to Impress Investors

July 24, 2024
graphical user interface, application

Airbnb Beats Q2 Estimates But Stock Falls 6.5% on Margin Pressure From $200M New Business Investments

August 7, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018